Update on Aflibercept BPCIA Litigation

In a sealed order that issued on June 11, the Court granted a permanent injunction in favor of Regeneron against Mylan/Biocon in the pending aflibercept BPCIA litigation. …
By: Goodwin
Previous Story

Permanent Injunction Issued Preventing Launch of EYLEA® Biosimilar Yesafili™

Next Story

Understanding Director Vidal’s Impact on Inter Partes Review Procedures